ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
125.805 IP-LS
Project title
Advancing AAV gene therapies with synthetic biology solutions

Texts for this project
 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Life sciences, Biotechnology and processing
Abstract
(English)
AAV vectors are key for gene therapy, but current production methods face scalability and cost challenges. We develop producer cell lines with orthogonal ligand-inducible gene switches to optimize AAV yields, quality, and potency, advancing gene therapy production and metabolic disease treatment.